Investment Thesis
Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with strong brands in tissue, personal care, and incontinence products. The company is poised for margin recovery driven by cost savings, premium product mix, and pricing power. With a robust balance sheet and commitment to sustainability, Essity offers a defensive yet growing profile in the consumer staples space.
12-Month Catalysts
- Margin expansion from restructuring and cost efficiency programs, targeting 100-200 bps improvement in EBIT margin.
- Innovation in sustainable products (e.g., plant-based diapers, recycled tissue) driving market share gains.
- Potential divestiture of non-core assets (e.g., Vinda) to unlock value and reduce debt.
Key Risks
- Raw material cost volatility (pulp, energy) could pressure margins.
- Intense competition from private labels and larger peers (P&G, Kimberly-Clark).
Valuation
Essity trades at ~15x forward P/E, a discount to its historical average and peers, with a dividend yield of ~3.5%. The margin recovery story supports a re-rating to 18x, implying ~20% upside.
Balance Sheet
Net debt/EBITDA of ~1.5x, strong free cash flow conversion (>80%), and investment-grade credit rating provide financial flexibility.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Past performance does not guarantee future results.